318 related articles for article (PubMed ID: 33297907)
1. ROS-Responsive Nanomedicine: Towards Targeting the Breast Tumor Microenvironment.
Malla RR; Kamal MA
Curr Med Chem; 2021; 28(28):5674-5698. PubMed ID: 33297907
[TBL] [Abstract][Full Text] [Related]
2. Reactive oxygen species (ROS): Critical roles in breast tumor microenvironment.
Malla R; Surepalli N; Farran B; Malhotra SV; Nagaraju GP
Crit Rev Oncol Hematol; 2021 Apr; 160():103285. PubMed ID: 33716202
[TBL] [Abstract][Full Text] [Related]
3. Efficacy-shaping nanomedicine by loading Calcium Peroxide into Tumor Microenvironment-responsive Nanoparticles for the Antitumor Therapy of Prostate Cancer.
Wu D; Zhu ZQ; Tang HX; Shi ZE; Kang J; Liu Q; Qi J
Theranostics; 2020; 10(21):9808-9829. PubMed ID: 32863961
[No Abstract] [Full Text] [Related]
4. Recent advances of redox-responsive nanoplatforms for tumor theranostics.
Chen M; Liu D; Liu F; Wu Y; Peng X; Song F
J Control Release; 2021 Apr; 332():269-284. PubMed ID: 33662455
[TBL] [Abstract][Full Text] [Related]
5. Tumor microenvironment-responsive dynamic inorganic nanoassemblies for cancer imaging and treatment.
Yang Y; Wu H; Liu B; Liu Z
Adv Drug Deliv Rev; 2021 Dec; 179():114004. PubMed ID: 34662672
[TBL] [Abstract][Full Text] [Related]
6. Nanomedicine-based strategies to target and modulate the tumor microenvironment.
Mendes BB; Sousa DP; Conniot J; Conde J
Trends Cancer; 2021 Sep; 7(9):847-862. PubMed ID: 34090865
[TBL] [Abstract][Full Text] [Related]
7. Nanoparticle drug delivery systems responsive to tumor microenvironment: Promising alternatives in the treatment of triple-negative breast cancer.
Cao Y; Meng F; Cai T; Gao L; Lee J; Solomevich SO; Aharodnikau UE; Guo T; Lan M; Liu F; Li Q; Viktor T; Li D; Cai Y
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2024; 16(2):e1950. PubMed ID: 38528388
[TBL] [Abstract][Full Text] [Related]
8. Gold Cube-in-Cube Based Oxygen Nanogenerator: A Theranostic Nanoplatform for Modulating Tumor Microenvironment for Precise Chemo-Phototherapy and Multimodal Imaging.
Zhang X; Xi Z; Machuki JO; Luo J; Yang D; Li J; Cai W; Yang Y; Zhang L; Tian J; Guo K; Yu Y; Gao F
ACS Nano; 2019 May; 13(5):5306-5325. PubMed ID: 31018094
[TBL] [Abstract][Full Text] [Related]
9. Strategies targeting tumor immune and stromal microenvironment and their clinical relevance.
Hu M; Huang L
Adv Drug Deliv Rev; 2022 Apr; 183():114137. PubMed ID: 35143893
[TBL] [Abstract][Full Text] [Related]
10. Combined cancer therapeutics-Tackling the complexity of the tumor microenvironment.
Roma-Rodrigues C; Raposo LR; Valente R; Fernandes AR; Baptista PV
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2021 Sep; 13(5):e1704. PubMed ID: 33565269
[TBL] [Abstract][Full Text] [Related]
11. Remodeling tumor microenvironment with nanomedicines.
Martin JD; Miyazaki T; Cabral H
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2021 Nov; 13(6):e1730. PubMed ID: 34124849
[TBL] [Abstract][Full Text] [Related]
12. Recent advances of polymeric nanoplatforms for cancer treatment: smart delivery systems (SDS), nanotheranostics and multidrug resistance (MDR) inhibition.
Gupta U; Maity D; Sharma VK
Biomed Mater; 2023 Nov; 19(1):. PubMed ID: 37944188
[TBL] [Abstract][Full Text] [Related]
13. Responsive Role of Nanomedicine in the Tumor Microenvironment and Cancer Drug Resistance.
Sa P; Sahoo SK; Dilnawaz F
Curr Med Chem; 2023; 30(29):3335-3355. PubMed ID: 36154585
[TBL] [Abstract][Full Text] [Related]
14. Stromal barriers to nanomedicine penetration in the pancreatic tumor microenvironment.
Tanaka HY; Kano MR
Cancer Sci; 2018 Jul; 109(7):2085-2092. PubMed ID: 29737600
[TBL] [Abstract][Full Text] [Related]
15. Tumor microenvironment-regulating nanomedicine design to fight multi-drug resistant tumors.
Xu Q; Lan X; Lin H; Xi Q; Wang M; Quan X; Yao G; Yu Z; Wang Y; Yu M
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2023 Jan; 15(1):e1842. PubMed ID: 35989568
[TBL] [Abstract][Full Text] [Related]
16. Nano-Strategies to Target Breast Cancer-Associated Fibroblasts: Rearranging the Tumor Microenvironment to Achieve Antitumor Efficacy.
Truffi M; Mazzucchelli S; Bonizzi A; Sorrentino L; Allevi R; Vanna R; Morasso C; Corsi F
Int J Mol Sci; 2019 Mar; 20(6):. PubMed ID: 30871158
[TBL] [Abstract][Full Text] [Related]
17. Tumor Microenvironment and Nitric Oxide: Concepts and Mechanisms.
Vedenko A; Panara K; Goldstein G; Ramasamy R; Arora H
Adv Exp Med Biol; 2020; 1277():143-158. PubMed ID: 33119871
[TBL] [Abstract][Full Text] [Related]
18. Biopolymer-based tumor microenvironment-responsive nanomedicine for targeted cancer therapy.
Jha A; Kumar M; Bharti K; Manjit M; Mishra B
Nanomedicine (Lond); 2024 Mar; 19(7):633-651. PubMed ID: 38445583
[TBL] [Abstract][Full Text] [Related]
19. Nanomedicine as a multimodal therapeutic paradigm against cancer: on the way forward in advancing precision therapy.
Sandbhor P; Palkar P; Bhat S; John G; Goda JS
Nanoscale; 2024 Mar; 16(13):6330-6364. PubMed ID: 38470224
[TBL] [Abstract][Full Text] [Related]
20. Deep-Tissue Fluorescence Imaging Study of Reactive Oxygen Species in a Tumor Microenvironment.
Wu C; Mao Y; Wang X; Li P; Tang B
Anal Chem; 2022 Jan; 94(1):165-176. PubMed ID: 34802229
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
